ANIP
ANI Pharmaceuticals Inc
Price:  
62.12 
USD
Volume:  
199,519.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ANIP EV/EBITDA

-142.2%
Upside

As of 2025-06-13, the EV/EBITDA ratio of ANI Pharmaceuticals Inc (ANIP) is -50.08. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ANIP's latest enterprise value is 1,817.92 mil USD. ANIP's TTM EBITDA according to its financial statements is -36.30 mil USD. Dividing these 2 quantities gives us the above ANIP EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.0x - 9.6x 8.8x
Forward P/E multiples 8.5x - 10.6x 10.4x
Fair Price (35.29) - (15.67) (26.19)
Upside -156.8% - -125.2% -142.2%
62.12 USD
Stock Price
(26.19) USD
Fair Price

ANIP EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-10 -50.53
2025-06-09 -50.72
2025-06-06 -49.99
2025-06-05 -48.75
2025-06-04 -49.34
2025-06-03 -49.81
2025-06-02 -49.96
2025-05-30 -48.06
2025-05-29 -47.78
2025-05-28 -47.51
2025-05-27 -47.82
2025-05-23 -47.50
2025-05-22 -47.19
2025-05-21 -48.27
2025-05-20 -49.20
2025-05-19 -48.91
2025-05-16 -48.81
2025-05-15 -48.54
2025-05-14 -49.04
2025-05-13 -50.01
2025-05-12 -50.19
2025-05-09 -52.58
2025-05-08 -55.70
2025-05-07 -55.27
2025-05-06 -54.94
2025-05-05 -56.31
2025-05-02 -56.54
2025-05-01 -55.19
2025-04-30 -55.27
2025-04-29 -55.24
2025-04-28 -55.23
2025-04-25 -54.68
2025-04-24 -54.57
2025-04-23 -53.81
2025-04-22 -54.16
2025-04-21 -53.59
2025-04-17 -54.31
2025-04-16 -54.31
2025-04-15 -54.51
2025-04-14 -54.02
2025-04-11 -53.66
2025-04-10 -51.87
2025-04-09 -52.40
2025-04-08 -50.64
2025-04-07 -52.99
2025-04-04 -53.30
2025-04-03 -53.76
2025-04-02 -54.40
2025-04-01 -53.60
2025-03-31 -52.96